nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.018	0.0432	CbGpPWpGaD
Isotretinoin—RARG—tongue—hypothyroidism	0.0165	0.0796	CbGeAlD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0165	0.0395	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0162	0.0387	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0155	0.0371	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0155	0.0371	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—THRA—hypothyroidism	0.0133	0.0319	CbGpPWpGaD
Isotretinoin—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.013	0.0347	CcSEcCtD
Isotretinoin—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.013	0.0347	CcSEcCtD
Isotretinoin—RXRG—Nuclear Receptors—THRA—hypothyroidism	0.0122	0.0292	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—THRA—hypothyroidism	0.0119	0.0286	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.0116	0.0278	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—THRA—hypothyroidism	0.0115	0.0274	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—THRA—hypothyroidism	0.0115	0.0274	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.0106	0.0255	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0105	0.0252	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.0104	0.025	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.01	0.0239	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.01	0.0239	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00963	0.023	CbGpPWpGaD
Isotretinoin—Benign intracranial hypertension—Liotrix—hypothyroidism	0.00956	0.0255	CcSEcCtD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00944	0.0226	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00905	0.0217	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00905	0.0217	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—THRB—hypothyroidism	0.00858	0.0205	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00809	0.0194	CbGpPWpGaD
Isotretinoin—Renal tubular necrosis—Liotrix—hypothyroidism	0.00787	0.021	CcSEcCtD
Isotretinoin—Clotting—Liotrix—hypothyroidism	0.00787	0.021	CcSEcCtD
Isotretinoin—RXRG—Nuclear Receptors—THRB—hypothyroidism	0.00785	0.0188	CbGpPWpGaD
Isotretinoin—RARB—heart—hypothyroidism	0.0077	0.0371	CbGeAlD
Isotretinoin—RARB—Nuclear Receptors—THRB—hypothyroidism	0.0077	0.0184	CbGpPWpGaD
Isotretinoin—RXRG—heart—hypothyroidism	0.00753	0.0362	CbGeAlD
Isotretinoin—RXRB—Nuclear Receptors—THRB—hypothyroidism	0.00738	0.0177	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—THRB—hypothyroidism	0.00738	0.0177	CbGpPWpGaD
Isotretinoin—RXRG—cardiovascular system—hypothyroidism	0.0071	0.0342	CbGeAlD
Isotretinoin—RXRB—heart—hypothyroidism	0.00708	0.0341	CbGeAlD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00678	0.0162	CbGpPWpGaD
Isotretinoin—Phlebitis—Liothyronine—hypothyroidism	0.00655	0.0175	CcSEcCtD
Isotretinoin—RXRG—pituitary gland—hypothyroidism	0.00629	0.0303	CbGeAlD
Isotretinoin—RARG—heart—hypothyroidism	0.00628	0.0302	CbGeAlD
Isotretinoin—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00623	0.0166	CcSEcCtD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0062	0.0149	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00608	0.0146	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—THRA—hypothyroidism	0.00597	0.0143	CbGpPWpGaD
Isotretinoin—RXRA—female gonad—hypothyroidism	0.00597	0.0287	CbGeAlD
Isotretinoin—RARA—heart—hypothyroidism	0.00591	0.0284	CbGeAlD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00583	0.014	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00583	0.014	CbGpPWpGaD
Isotretinoin—RARB—adrenal gland—hypothyroidism	0.00575	0.0277	CbGeAlD
Isotretinoin—RXRG—adrenal gland—hypothyroidism	0.00562	0.027	CbGeAlD
Isotretinoin—RARB—thyroid gland—hypothyroidism	0.00555	0.0267	CbGeAlD
Isotretinoin—RXRG—thyroid gland—hypothyroidism	0.00542	0.0261	CbGeAlD
Isotretinoin—RARB—female gonad—hypothyroidism	0.00536	0.0258	CbGeAlD
Isotretinoin—RXRB—adrenal gland—hypothyroidism	0.00528	0.0254	CbGeAlD
Isotretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—NKX2-5—hypothyroidism	0.00528	0.0126	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00521	0.0125	CbGpPWpGaD
Isotretinoin—RXRB—thyroid gland—hypothyroidism	0.0051	0.0245	CbGeAlD
Isotretinoin—Acidosis—Liotrix—hypothyroidism	0.00508	0.0136	CcSEcCtD
Isotretinoin—RARA—gonad—hypothyroidism	0.00506	0.0243	CbGeAlD
Isotretinoin—RXRA—liver—hypothyroidism	0.005	0.0241	CbGeAlD
Isotretinoin—RARA—pituitary gland—hypothyroidism	0.00494	0.0237	CbGeAlD
Isotretinoin—RXRB—female gonad—hypothyroidism	0.00493	0.0237	CbGeAlD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00472	0.0113	CbGpPWpGaD
Isotretinoin—RARG—adrenal gland—hypothyroidism	0.00469	0.0226	CbGeAlD
Isotretinoin—RARG—blood—hypothyroidism	0.00469	0.0226	CbGeAlD
Isotretinoin—RXRG—testis—hypothyroidism	0.00465	0.0224	CbGeAlD
Isotretinoin—RARG—thyroid gland—hypothyroidism	0.00453	0.0218	CbGeAlD
Isotretinoin—Fluid overload—Liotrix—hypothyroidism	0.00452	0.0121	CcSEcCtD
Isotretinoin—RARB—liver—hypothyroidism	0.0045	0.0216	CbGeAlD
Isotretinoin—RARA—adrenal gland—hypothyroidism	0.00441	0.0212	CbGeAlD
Isotretinoin—RARA—blood—hypothyroidism	0.00441	0.0212	CbGeAlD
Isotretinoin—RARB—cerebellum—hypothyroidism	0.00439	0.0211	CbGeAlD
Isotretinoin—RARG—female gonad—hypothyroidism	0.00437	0.021	CbGeAlD
Isotretinoin—RXRB—testis—hypothyroidism	0.00437	0.021	CbGeAlD
Isotretinoin—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00429	0.0115	CcSEcCtD
Isotretinoin—Myocardial infarction—Liothyronine—hypothyroidism	0.00427	0.0114	CcSEcCtD
Isotretinoin—RARA—thyroid gland—hypothyroidism	0.00426	0.0205	CbGeAlD
Isotretinoin—RXRB—liver—hypothyroidism	0.00413	0.0199	CbGeAlD
Isotretinoin—RARA—female gonad—hypothyroidism	0.00411	0.0198	CbGeAlD
Isotretinoin—RXRB—cerebellum—hypothyroidism	0.00404	0.0194	CbGeAlD
Isotretinoin—Cyanosis—Liotrix—hypothyroidism	0.00397	0.0106	CcSEcCtD
Isotretinoin—RARG—testis—hypothyroidism	0.00388	0.0187	CbGeAlD
Isotretinoin—RXRA—Nuclear Receptors—THRB—hypothyroidism	0.00385	0.00921	CbGpPWpGaD
Isotretinoin—Wheezing—Levothyroxine—hypothyroidism	0.00371	0.00991	CcSEcCtD
Isotretinoin—Wheezing—Dextrothyroxine—hypothyroidism	0.00371	0.00991	CcSEcCtD
Isotretinoin—RARA—testis—hypothyroidism	0.00365	0.0175	CbGeAlD
Isotretinoin—Coagulopathy—Liotrix—hypothyroidism	0.00361	0.00964	CcSEcCtD
Isotretinoin—RARG—cerebellum—hypothyroidism	0.00358	0.0172	CbGeAlD
Isotretinoin—Tingling sensation—Liotrix—hypothyroidism	0.0035	0.00934	CcSEcCtD
Isotretinoin—Coma—Levothyroxine—hypothyroidism	0.00349	0.00932	CcSEcCtD
Isotretinoin—Coma—Dextrothyroxine—hypothyroidism	0.00349	0.00932	CcSEcCtD
Isotretinoin—Arrhythmia—Liothyronine—hypothyroidism	0.00349	0.00932	CcSEcCtD
Isotretinoin—RARA—liver—hypothyroidism	0.00345	0.0166	CbGeAlD
Isotretinoin—RARA—cerebellum—hypothyroidism	0.00337	0.0162	CbGeAlD
Isotretinoin—Tenderness—Liotrix—hypothyroidism	0.00322	0.0086	CcSEcCtD
Isotretinoin—Cellulitis—Liotrix—hypothyroidism	0.00309	0.00825	CcSEcCtD
Isotretinoin—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00306	0.00817	CcSEcCtD
Isotretinoin—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00306	0.00817	CcSEcCtD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00304	0.00728	CbGpPWpGaD
Isotretinoin—Ulcer—Liotrix—hypothyroidism	0.00297	0.00794	CcSEcCtD
Isotretinoin—Hypertension—Liothyronine—hypothyroidism	0.00294	0.00784	CcSEcCtD
Isotretinoin—Cardiac failure—Levothyroxine—hypothyroidism	0.00284	0.00759	CcSEcCtD
Isotretinoin—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00284	0.00759	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00282	0.00676	CbGpPWpGaD
Isotretinoin—Affect lability—Dextrothyroxine—hypothyroidism	0.00273	0.00729	CcSEcCtD
Isotretinoin—Affect lability—Levothyroxine—hypothyroidism	0.00273	0.00729	CcSEcCtD
Isotretinoin—Wheezing—Liotrix—hypothyroidism	0.00273	0.00729	CcSEcCtD
Isotretinoin—Tachycardia—Liothyronine—hypothyroidism	0.00271	0.00723	CcSEcCtD
Isotretinoin—Irritability—Dextrothyroxine—hypothyroidism	0.00265	0.00707	CcSEcCtD
Isotretinoin—Irritability—Levothyroxine—hypothyroidism	0.00265	0.00707	CcSEcCtD
Isotretinoin—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00264	0.00704	CcSEcCtD
Isotretinoin—Cardiac arrest—Levothyroxine—hypothyroidism	0.00264	0.00704	CcSEcCtD
Isotretinoin—Mood swings—Dextrothyroxine—hypothyroidism	0.00263	0.00702	CcSEcCtD
Isotretinoin—Mood swings—Levothyroxine—hypothyroidism	0.00263	0.00702	CcSEcCtD
Isotretinoin—Hypotension—Liothyronine—hypothyroidism	0.00259	0.00693	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00258	0.00618	CbGpPWpGaD
Isotretinoin—Dehydration—Levothyroxine—hypothyroidism	0.00258	0.00689	CcSEcCtD
Isotretinoin—Dehydration—Dextrothyroxine—hypothyroidism	0.00258	0.00689	CcSEcCtD
Isotretinoin—Coma—Liotrix—hypothyroidism	0.00257	0.00686	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00253	0.00606	CbGpPWpGaD
Isotretinoin—Lightheadedness—Liotrix—hypothyroidism	0.00251	0.00672	CcSEcCtD
Isotretinoin—Sepsis—Liotrix—hypothyroidism	0.00244	0.00651	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00243	0.00581	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00243	0.00581	CbGpPWpGaD
Isotretinoin—Dysphagia—Dextrothyroxine—hypothyroidism	0.0024	0.0064	CcSEcCtD
Isotretinoin—Dysphagia—Levothyroxine—hypothyroidism	0.0024	0.0064	CcSEcCtD
Isotretinoin—Phlebitis—Liotrix—hypothyroidism	0.00237	0.00632	CcSEcCtD
Isotretinoin—Sweating increased—Dextrothyroxine—hypothyroidism	0.00233	0.00624	CcSEcCtD
Isotretinoin—Sweating increased—Levothyroxine—hypothyroidism	0.00233	0.00624	CcSEcCtD
Isotretinoin—Swelling—Liotrix—hypothyroidism	0.00231	0.00618	CcSEcCtD
Isotretinoin—Cardiac failure congestive—Liotrix—hypothyroidism	0.00225	0.00601	CcSEcCtD
Isotretinoin—Renal failure acute—Liotrix—hypothyroidism	0.00221	0.0059	CcSEcCtD
Isotretinoin—Body temperature increased—Liothyronine—hypothyroidism	0.00219	0.00586	CcSEcCtD
Isotretinoin—Weight decreased—Levothyroxine—hypothyroidism	0.00217	0.00579	CcSEcCtD
Isotretinoin—Weight decreased—Dextrothyroxine—hypothyroidism	0.00217	0.00579	CcSEcCtD
Isotretinoin—Renal impairment—Liotrix—hypothyroidism	0.00214	0.00572	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00211	0.00563	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00211	0.00563	CcSEcCtD
Isotretinoin—Myocardial infarction—Levothyroxine—hypothyroidism	0.00209	0.0056	CcSEcCtD
Isotretinoin—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00209	0.0056	CcSEcCtD
Isotretinoin—Cardiac failure—Liotrix—hypothyroidism	0.00209	0.00558	CcSEcCtD
Isotretinoin—Cerebrovascular accident—Liotrix—hypothyroidism	0.00208	0.00556	CcSEcCtD
Isotretinoin—Sweating—Dextrothyroxine—hypothyroidism	0.00205	0.00547	CcSEcCtD
Isotretinoin—Sweating—Levothyroxine—hypothyroidism	0.00205	0.00547	CcSEcCtD
Isotretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00202	0.00484	CbGpPWpGaD
Isotretinoin—Affect lability—Liotrix—hypothyroidism	0.00201	0.00536	CcSEcCtD
Isotretinoin—Irritability—Liotrix—hypothyroidism	0.00195	0.0052	CcSEcCtD
Isotretinoin—Cardiac arrest—Liotrix—hypothyroidism	0.00194	0.00518	CcSEcCtD
Isotretinoin—Mood swings—Liotrix—hypothyroidism	0.00193	0.00516	CcSEcCtD
Isotretinoin—Blood creatinine increased—Liotrix—hypothyroidism	0.00191	0.0051	CcSEcCtD
Isotretinoin—Dehydration—Liotrix—hypothyroidism	0.0019	0.00507	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—THRA—hypothyroidism	0.00182	0.00435	CbGpPWpGaD
Isotretinoin—Flushing—Dextrothyroxine—hypothyroidism	0.00178	0.00476	CcSEcCtD
Isotretinoin—Flushing—Levothyroxine—hypothyroidism	0.00178	0.00476	CcSEcCtD
Isotretinoin—Abdominal distension—Liotrix—hypothyroidism	0.00177	0.00474	CcSEcCtD
Isotretinoin—Dysphagia—Liotrix—hypothyroidism	0.00176	0.00471	CcSEcCtD
Isotretinoin—Bronchospasm—Liotrix—hypothyroidism	0.00173	0.00463	CcSEcCtD
Isotretinoin—Sweating increased—Liotrix—hypothyroidism	0.00172	0.00459	CcSEcCtD
Isotretinoin—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00171	0.00458	CcSEcCtD
Isotretinoin—Arrhythmia—Levothyroxine—hypothyroidism	0.00171	0.00458	CcSEcCtD
Isotretinoin—Alopecia—Levothyroxine—hypothyroidism	0.0017	0.00453	CcSEcCtD
Isotretinoin—Alopecia—Dextrothyroxine—hypothyroidism	0.0017	0.00453	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—THRA—hypothyroidism	0.00166	0.00398	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC5A7—hypothyroidism	0.00166	0.00397	CbGpPWpGaD
Isotretinoin—Tension—Levothyroxine—hypothyroidism	0.00164	0.00438	CcSEcCtD
Isotretinoin—Tension—Dextrothyroxine—hypothyroidism	0.00164	0.00438	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—THRA—hypothyroidism	0.00163	0.0039	CbGpPWpGaD
Isotretinoin—Nervousness—Dextrothyroxine—hypothyroidism	0.00162	0.00433	CcSEcCtD
Isotretinoin—Nervousness—Levothyroxine—hypothyroidism	0.00162	0.00433	CcSEcCtD
Isotretinoin—Weight decreased—Liotrix—hypothyroidism	0.00159	0.00426	CcSEcCtD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.00156	0.00375	CbGpPWpGaD
Isotretinoin—Tremor—Levothyroxine—hypothyroidism	0.00156	0.00418	CcSEcCtD
Isotretinoin—Tremor—Dextrothyroxine—hypothyroidism	0.00156	0.00418	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—THRA—hypothyroidism	0.00156	0.00374	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—THRA—hypothyroidism	0.00156	0.00374	CbGpPWpGaD
Isotretinoin—Acute coronary syndrome—Liotrix—hypothyroidism	0.00155	0.00414	CcSEcCtD
Isotretinoin—Renal failure—Liotrix—hypothyroidism	0.00155	0.00413	CcSEcCtD
Isotretinoin—Myocardial infarction—Liotrix—hypothyroidism	0.00154	0.00412	CcSEcCtD
Isotretinoin—Agitation—Dextrothyroxine—hypothyroidism	0.00153	0.0041	CcSEcCtD
Isotretinoin—Agitation—Levothyroxine—hypothyroidism	0.00153	0.0041	CcSEcCtD
Isotretinoin—RXRA—Endogenous sterols—POMC—hypothyroidism	0.00152	0.00364	CbGpPWpGaD
Isotretinoin—Sweating—Liotrix—hypothyroidism	0.00151	0.00403	CcSEcCtD
Isotretinoin—Palpitations—Levothyroxine—hypothyroidism	0.00148	0.00394	CcSEcCtD
Isotretinoin—Palpitations—Dextrothyroxine—hypothyroidism	0.00148	0.00394	CcSEcCtD
Isotretinoin—Convulsion—Levothyroxine—hypothyroidism	0.00145	0.00386	CcSEcCtD
Isotretinoin—Convulsion—Dextrothyroxine—hypothyroidism	0.00145	0.00386	CcSEcCtD
Isotretinoin—Arthralgia—Dextrothyroxine—hypothyroidism	0.00142	0.0038	CcSEcCtD
Isotretinoin—Arthralgia—Levothyroxine—hypothyroidism	0.00142	0.0038	CcSEcCtD
Isotretinoin—Anxiety—Dextrothyroxine—hypothyroidism	0.00142	0.00378	CcSEcCtD
Isotretinoin—Anxiety—Levothyroxine—hypothyroidism	0.00142	0.00378	CcSEcCtD
Isotretinoin—Hypoaesthesia—Liotrix—hypothyroidism	0.0014	0.00375	CcSEcCtD
Isotretinoin—Confusional state—Levothyroxine—hypothyroidism	0.00137	0.00367	CcSEcCtD
Isotretinoin—Confusional state—Dextrothyroxine—hypothyroidism	0.00137	0.00367	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ZNF764—hypothyroidism	0.00136	0.00325	CbGpPWpGaD
Isotretinoin—Shock—Dextrothyroxine—hypothyroidism	0.00134	0.00358	CcSEcCtD
Isotretinoin—Shock—Levothyroxine—hypothyroidism	0.00134	0.00358	CcSEcCtD
Isotretinoin—Tachycardia—Dextrothyroxine—hypothyroidism	0.00133	0.00355	CcSEcCtD
Isotretinoin—Tachycardia—Levothyroxine—hypothyroidism	0.00133	0.00355	CcSEcCtD
Isotretinoin—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00132	0.00352	CcSEcCtD
Isotretinoin—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00132	0.00352	CcSEcCtD
Isotretinoin—Flushing—Liotrix—hypothyroidism	0.00131	0.0035	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.0013	0.0031	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00126	0.00303	CbGpPWpGaD
Isotretinoin—Arrhythmia—Liotrix—hypothyroidism	0.00126	0.00337	CcSEcCtD
Isotretinoin—Alopecia—Liotrix—hypothyroidism	0.00125	0.00333	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ZNF764—hypothyroidism	0.00124	0.00297	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00124	0.00332	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00124	0.00332	CcSEcCtD
Isotretinoin—Insomnia—Levothyroxine—hypothyroidism	0.00123	0.00329	CcSEcCtD
Isotretinoin—Insomnia—Dextrothyroxine—hypothyroidism	0.00123	0.00329	CcSEcCtD
Isotretinoin—RARB—Gene Expression—ZNF764—hypothyroidism	0.00122	0.00292	CbGpPWpGaD
Isotretinoin—Dyspnoea—Levothyroxine—hypothyroidism	0.00122	0.00325	CcSEcCtD
Isotretinoin—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00122	0.00325	CcSEcCtD
Isotretinoin—Flatulence—Liotrix—hypothyroidism	0.00121	0.00323	CcSEcCtD
Isotretinoin—Tension—Liotrix—hypothyroidism	0.00121	0.00322	CcSEcCtD
Isotretinoin—Nervousness—Liotrix—hypothyroidism	0.00119	0.00319	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00119	0.00284	CbGpPWpGaD
Isotretinoin—Fatigue—Levothyroxine—hypothyroidism	0.00118	0.00314	CcSEcCtD
Isotretinoin—Fatigue—Dextrothyroxine—hypothyroidism	0.00118	0.00314	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—THRB—hypothyroidism	0.00117	0.00281	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ZNF764—hypothyroidism	0.00117	0.0028	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ZNF764—hypothyroidism	0.00117	0.0028	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00116	0.00278	CbGpPWpGaD
Isotretinoin—Vision blurred—Liotrix—hypothyroidism	0.00116	0.00309	CcSEcCtD
Isotretinoin—Tremor—Liotrix—hypothyroidism	0.00115	0.00307	CcSEcCtD
Isotretinoin—RXRA—Circadian Clock—AVP—hypothyroidism	0.00114	0.00273	CbGpPWpGaD
Isotretinoin—Agitation—Liotrix—hypothyroidism	0.00113	0.00302	CcSEcCtD
Isotretinoin—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00112	0.003	CcSEcCtD
Isotretinoin—Feeling abnormal—Levothyroxine—hypothyroidism	0.00112	0.003	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00111	0.00298	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00111	0.00298	CcSEcCtD
Isotretinoin—RXRB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00111	0.00267	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00111	0.00267	CbGpPWpGaD
Isotretinoin—Syncope—Liotrix—hypothyroidism	0.0011	0.00294	CcSEcCtD
Isotretinoin—Palpitations—Liotrix—hypothyroidism	0.00109	0.0029	CcSEcCtD
Isotretinoin—Urticaria—Dextrothyroxine—hypothyroidism	0.00108	0.00289	CcSEcCtD
Isotretinoin—Urticaria—Levothyroxine—hypothyroidism	0.00108	0.00289	CcSEcCtD
Isotretinoin—Loss of consciousness—Liotrix—hypothyroidism	0.00108	0.00288	CcSEcCtD
Isotretinoin—Body temperature increased—Levothyroxine—hypothyroidism	0.00108	0.00288	CcSEcCtD
Isotretinoin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00108	0.00288	CcSEcCtD
Isotretinoin—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00108	0.00288	CcSEcCtD
Isotretinoin—Abdominal pain—Levothyroxine—hypothyroidism	0.00108	0.00288	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—THRB—hypothyroidism	0.00107	0.00257	CbGpPWpGaD
Isotretinoin—Convulsion—Liotrix—hypothyroidism	0.00106	0.00284	CcSEcCtD
Isotretinoin—Hypertension—Liotrix—hypothyroidism	0.00106	0.00283	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—THRB—hypothyroidism	0.00105	0.00252	CbGpPWpGaD
Isotretinoin—Arthralgia—Liotrix—hypothyroidism	0.00105	0.00279	CcSEcCtD
Isotretinoin—Chest pain—Liotrix—hypothyroidism	0.00105	0.00279	CcSEcCtD
Isotretinoin—Anxiety—Liotrix—hypothyroidism	0.00104	0.00278	CcSEcCtD
Isotretinoin—Confusional state—Liotrix—hypothyroidism	0.00101	0.0027	CcSEcCtD
Isotretinoin—RXRB—Generic Transcription Pathway—THRB—hypothyroidism	0.00101	0.00241	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—THRB—hypothyroidism	0.00101	0.00241	CbGpPWpGaD
Isotretinoin—Oedema—Liotrix—hypothyroidism	0.001	0.00268	CcSEcCtD
Isotretinoin—Anaphylactic shock—Liotrix—hypothyroidism	0.001	0.00268	CcSEcCtD
Isotretinoin—Infection—Liotrix—hypothyroidism	0.000996	0.00266	CcSEcCtD
Isotretinoin—Shock—Liotrix—hypothyroidism	0.000986	0.00263	CcSEcCtD
Isotretinoin—Tachycardia—Liotrix—hypothyroidism	0.000978	0.00261	CcSEcCtD
Isotretinoin—Asthenia—Dextrothyroxine—hypothyroidism	0.000978	0.00261	CcSEcCtD
Isotretinoin—Asthenia—Levothyroxine—hypothyroidism	0.000978	0.00261	CcSEcCtD
Isotretinoin—Hyperhidrosis—Liotrix—hypothyroidism	0.000969	0.00259	CcSEcCtD
Isotretinoin—Pruritus—Levothyroxine—hypothyroidism	0.000964	0.00258	CcSEcCtD
Isotretinoin—Pruritus—Dextrothyroxine—hypothyroidism	0.000964	0.00258	CcSEcCtD
Isotretinoin—Anorexia—Liotrix—hypothyroidism	0.000956	0.00255	CcSEcCtD
Isotretinoin—Hypotension—Liotrix—hypothyroidism	0.000937	0.0025	CcSEcCtD
Isotretinoin—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000933	0.00249	CcSEcCtD
Isotretinoin—Diarrhoea—Levothyroxine—hypothyroidism	0.000933	0.00249	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000913	0.00244	CcSEcCtD
Isotretinoin—Insomnia—Liotrix—hypothyroidism	0.000907	0.00242	CcSEcCtD
Isotretinoin—Paraesthesia—Liotrix—hypothyroidism	0.0009	0.0024	CcSEcCtD
Isotretinoin—Dyspnoea—Liotrix—hypothyroidism	0.000894	0.00239	CcSEcCtD
Isotretinoin—RARG—Gene Expression—THRA—hypothyroidism	0.000876	0.0021	CbGpPWpGaD
Isotretinoin—Decreased appetite—Liotrix—hypothyroidism	0.000872	0.00233	CcSEcCtD
Isotretinoin—Vomiting—Levothyroxine—hypothyroidism	0.000867	0.00231	CcSEcCtD
Isotretinoin—Vomiting—Dextrothyroxine—hypothyroidism	0.000867	0.00231	CcSEcCtD
Isotretinoin—Fatigue—Liotrix—hypothyroidism	0.000864	0.00231	CcSEcCtD
Isotretinoin—Rash—Levothyroxine—hypothyroidism	0.000859	0.0023	CcSEcCtD
Isotretinoin—Rash—Dextrothyroxine—hypothyroidism	0.000859	0.0023	CcSEcCtD
Isotretinoin—Dermatitis—Levothyroxine—hypothyroidism	0.000859	0.00229	CcSEcCtD
Isotretinoin—Dermatitis—Dextrothyroxine—hypothyroidism	0.000859	0.00229	CcSEcCtD
Isotretinoin—Constipation—Liotrix—hypothyroidism	0.000857	0.00229	CcSEcCtD
Isotretinoin—Headache—Dextrothyroxine—hypothyroidism	0.000854	0.00228	CcSEcCtD
Isotretinoin—Headache—Levothyroxine—hypothyroidism	0.000854	0.00228	CcSEcCtD
Isotretinoin—Feeling abnormal—Liotrix—hypothyroidism	0.000826	0.00221	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Liotrix—hypothyroidism	0.00082	0.00219	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—THRA—hypothyroidism	0.000815	0.00195	CbGpPWpGaD
Isotretinoin—Nausea—Dextrothyroxine—hypothyroidism	0.00081	0.00216	CcSEcCtD
Isotretinoin—Nausea—Levothyroxine—hypothyroidism	0.00081	0.00216	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—THRA—hypothyroidism	0.000801	0.00192	CbGpPWpGaD
Isotretinoin—Urticaria—Liotrix—hypothyroidism	0.000796	0.00213	CcSEcCtD
Isotretinoin—Body temperature increased—Liotrix—hypothyroidism	0.000793	0.00212	CcSEcCtD
Isotretinoin—Abdominal pain—Liotrix—hypothyroidism	0.000793	0.00212	CcSEcCtD
Isotretinoin—RARB—Gene Expression—THRA—hypothyroidism	0.000785	0.00188	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—THRA—hypothyroidism	0.000753	0.0018	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—THRA—hypothyroidism	0.000753	0.0018	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IGF1—hypothyroidism	0.000747	0.00179	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Liotrix—hypothyroidism	0.000739	0.00197	CcSEcCtD
Isotretinoin—Asthenia—Liotrix—hypothyroidism	0.000719	0.00192	CcSEcCtD
Isotretinoin—Pruritus—Liotrix—hypothyroidism	0.000709	0.00189	CcSEcCtD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000706	0.00169	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IGF1—hypothyroidism	0.000702	0.00168	CbGpPWpGaD
Isotretinoin—Diarrhoea—Liotrix—hypothyroidism	0.000686	0.00183	CcSEcCtD
Isotretinoin—Dizziness—Liotrix—hypothyroidism	0.000663	0.00177	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—SLC5A5—hypothyroidism	0.000663	0.00159	CbGpPWpGaD
Isotretinoin—Vomiting—Liotrix—hypothyroidism	0.000637	0.0017	CcSEcCtD
Isotretinoin—Rash—Liotrix—hypothyroidism	0.000632	0.00169	CcSEcCtD
Isotretinoin—Dermatitis—Liotrix—hypothyroidism	0.000632	0.00169	CcSEcCtD
Isotretinoin—Headache—Liotrix—hypothyroidism	0.000628	0.00168	CcSEcCtD
Isotretinoin—RARG—Gene Expression—NKX2-5—hypothyroidism	0.000624	0.00149	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ZNF764—hypothyroidism	0.000609	0.00146	CbGpPWpGaD
Isotretinoin—Nausea—Liotrix—hypothyroidism	0.000595	0.00159	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000581	0.00139	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000573	0.00137	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NKX2-5—hypothyroidism	0.000571	0.00137	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—THRB—hypothyroidism	0.000564	0.00135	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NKX2-5—hypothyroidism	0.00056	0.00134	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000538	0.00129	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NKX2-5—hypothyroidism	0.000536	0.00128	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NKX2-5—hypothyroidism	0.000536	0.00128	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000531	0.00127	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—THRB—hypothyroidism	0.000525	0.00126	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000516	0.00124	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—THRB—hypothyroidism	0.000516	0.00124	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—THRB—hypothyroidism	0.000506	0.00121	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—THRB—hypothyroidism	0.000485	0.00116	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—THRB—hypothyroidism	0.000485	0.00116	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00044	0.00105	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CLTC—hypothyroidism	0.000433	0.00104	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—THRA—hypothyroidism	0.000392	0.000939	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IGF1—hypothyroidism	0.000366	0.000876	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—IYD—hypothyroidism	0.000359	0.000859	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ATP5O—hypothyroidism	0.000305	0.00073	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—POMC—hypothyroidism	0.000304	0.000728	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TPO—hypothyroidism	0.000287	0.000687	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NKX2-5—hypothyroidism	0.00028	0.000669	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000269	0.000644	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000266	0.000636	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—THRB—hypothyroidism	0.000253	0.000605	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000212	0.000508	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VAV3—hypothyroidism	0.000204	0.000489	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000167	0.0004	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TSHB—hypothyroidism	0.000133	0.000318	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3C2A—hypothyroidism	0.000118	0.000283	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000117	0.00028	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC5A5—hypothyroidism	9.94e-05	0.000238	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—POMC—hypothyroidism	5.2e-05	0.000125	CbGpPWpGaD
